U.S. Residents Novartis Oncology
4 Rare Diseases Go to Novartis Oncology
     

Atypical Chronic Myeloid Leukemia

Diagnosis
Clinically, aCML is characterized by anemia, thrombocytopenia, and, in 75% of cases, splenomegaly.

Pathology findings include:
  • Peripheral blood leukocytosis with increased numbers of mature and immature neutrophils
  • Prominent dysgranulopoiesis
  • No Philadelphia chromosome or Bcr-Abl fusion gene
  • Neutrophil precursors (eg, promyelocytes, myelocytes, and metamyelocytes) >10% of WBCs
  • Minimal absolute basophilia with basophils <2% of WBCs
  • Absolute monocytosis with monocytes typically <10% of WBCs
  • Hypercellular bone marrow with granulocytic proliferation and granulocytic dysplasia
  • <20% blasts in the blood or bone marrow
Reference:
    National Cancer Institute. Myelodysplastic/Myeloproliferative Diseases (PDQ®): Treatment. Health Professional Version. Available at: http://www.cancer.gov/cancertopics/pdq/treatment/mds-mpd/healthprofessional/allpages. Accessed April 24, 2006.
  Print This Page

Clinical trials

Rare Like Me

Disclaimer: This is an international website dedicated to rare diseases, and intended for healthcare professionals outside the US. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.
About Rare Diseases  |  DFSP  |  HES  |  Mast Cell Disease  |  Myelodysplastic / Myeloproliferative Diseases  |  Resources
Contact    |    Sitemap    |    Privacy
Use of this website is subject to our Terms of Use
©2009 Novartis AG